Cabozantinib significantly decreases tumor volume and prolongs survival in SCNPC PDX models. by Mark P. Labrecque (10011469)

Silencing of TET3 acted to decrease mitochondrial respiration in N2A cells. by Valeria Leon Kropf (17797623)

KIF15 mediates the trafficking of PSD95 along microtubules. by Xiaomei He (795333)

Effects of SQFZ or SQFZ + Cisplatin on the levels of PGE2, IL-6, IL-10, and CCL1 in MDA-MB-231/DDP+M2 xenografts. by Bin Yan (32980)

Subjects:

Effects of SQFZ or SQFZ + Cisplatin on the expressions of CD206 and CD86 in MDA-MB-231/DDP+M2 xenografts. by Bin Yan (32980)

Subjects:

Effects of SQFZ or SQFZ + Cisplatin on the expressions of p-PI3K, PI3K, P-gp, and ABCG2 in MDA-MB-231/DDP+M2 xenografts. by Bin Yan (32980)

Subjects:

SQFZ inhibits the expressions of P-gp, ABCG2, and Bcl-2 and increases that of Bax through the PI3K pathway. by Bin Yan (32980)

Subjects:

Effects of SQFZ or SQFZ + cisplatin on tumour growth in MDA-MB-231/DDP+M2 xenografts. by Bin Yan (32980)

Subjects:

Sensitivities of MDA-MB-231/DDP cells to SQFZ and SQFZ + Cisplatin. by Bin Yan (32980)

Subjects:

SQFZ reverses constitutive and PI3K pathway-induced cisplatin resistance. by Bin Yan (32980)

Subjects:

Loss of zinc acquisition genes in <i>C</i>. <i>albicans</i> decreases damage potential by impairing growth during infection of IECs. by Jakob L. Sprague (18087148)

Marginal means – Pooled across scenarios. by Mehdi Mourali (10170245)

“…When are individuals more likely to support equal treatment algorithms (ETAs), characterized by higher predictive accuracy, and when do they prefer equal impact algorithms (EIAs) that reduce performance gaps between groups? A randomized conjoint experiment and a follow-up choice experiment revealed that support for the EIAs decreased sharply as their accuracy gap grew, although impact parity was prioritized more when ETAs produced large outcome discrepancies. …”

H2-K^b overexpression decreases NSPC proliferation and impairs adult hippocampal neurogenesis. by Karin Lin (11037548)

Summary of the effect of MPDD on SDLP across all participants, and also participants categorized by driving styles (“NS” (no significant), “+” (significant increase), and “-” (sign... by Mobina Faqani (22783963)

BLyS^-/- significantly decreased IgM and IgG secreting cells. by Natalie M. Bath (6316517)

Subjects:

Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

“…Results are presented as mean ± SD. Ceramide: CER, Evogliptin: EVO. *(P < 0.05) significant vs. control group; ^$(P < 0.05) significant vs. …”

Inhibition of LDHA leads to decreased ATP, reduced AKT phosphorylation, and enhanced chemotherapy sensitivity to LBP in A549 and NCL-H1975 cells. by Siyu Yuan (7425719)

Subjects:

FBP primarily decreases the protein level of HMGB1 by promoting its lysosomal degradation upon viral infection. by Penghui Hu (695020)

Mean interval from initial diagnosis to initiation of non-pharmacological treatment by year. by Mingee Choi (15250732)

Subjects:

Summary of the effect of MPDD on ART and TIBL across all participants, and also participants categorized by driving styles (“NS” (no significant), “+” (significant increase), and “... by Mobina Faqani (22783963)